Fetal Growth Retardation
82
9
15
33
Key Insights
Highlights
Success Rate
87% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
6.1%
5 terminated out of 82 trials
86.8%
+0.3% vs benchmark
20%
16 trials in Phase 3/4
21%
7 of 33 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 33 completed trials
Clinical Trials (82)
DEUX OEUFs: Cracking the Potential of Eggs to Improve Child Growth and Development
Acute Effects of Maternal Exercise and the Growth Restricted Pregnancy
Investigating the Structured Use of Ultrasound Scanning for Fetal Growth
BEP Supplementation Research in Bangladesh (JiVitA-BEP-IR)
Placental Lesions in Fetal Growth Restrictions
LMWH for Treatment of Early Fetal Growth Restriction (HepaGrowth)
Cook´s Balloon Versus Dinoprostone for Labor Induction of Term Pregnancies With Fetal Growth Restriction
Antenatal Melatonin Supplementation for Neuroprotection in Fetal Growth Restriction
Fetal Magnetic Resonance Imaging: Z-score Reference Ranges for a Large Patient Population in Normal Neuroimaging Measurement
Validation of Sensors for Long-term Non-Invasive Fetal Monitoring
Third Trimester Screening of Fetal Growth Restriction
Cardiac Displacement From Third Trimester to Early Childhood
The Impact of Opioid and Cannabis Exposure on Fetal Growth
MRI Angiography of Physiological and Pathological Pregnancy Placentas Ex-vivo
Fetal Cardiac Function
Dilapan-S®: A Multicenter US E-registry
Vitamin D Versus Sildenafil Citrate in Fetal Growth Restriction
STV Analysis Versus Visual Evaluation of Cardiotocography in FGR
Bioimpedence and Arterial Function Monitoring at Birth and in Infants
Evaluation of Anterior Middle Brain Structures With Cerebrovascular Flow in Fetuses With Fetal Growth Restriction